PlainRecalls
FDA Devices Moderate Class II Terminated

Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.

Reported: August 12, 2020 Initiated: June 26, 2020 #Z-2753-2020

Product Description

Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.

Reason for Recall

Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.

Details

Recalling Firm
RANDOX LABORATORIES, LTD.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of Puerto Rico and WV.
Location
Crumlin Colorado Antrim

Frequently Asked Questions

What product was recalled?
Randox Lipase Assay: Lipase Colorimetric R2 Substrate - Product Usage: A Lipase test system is a device intended for the quantitative in vitro determination of Lipase in human serum and plasma.. Recalled by RANDOX LABORATORIES, LTD..
Why was this product recalled?
Randox have confirmed imprecision of quality control and patient samples when using specific Randox Lipase R2 Substrate batches.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 12, 2020. Severity: Moderate. Recall number: Z-2753-2020.